Announcements

18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Yuyan Jiang, Stanford University, USA
  • Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

  • Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
  • Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

  • Bishal Gyawali, Queen’s University, Canada

Healthcare:

  • Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

  • Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

  • Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
  • Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

  • Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

  • Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

  • Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

  • Filip Jansåker, Lund University, Lund, Sweden
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

  • Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
  • Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

  • Sneha Sethi, University of Adelaide, Australia
  • Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

  • Sonia Nath, University of Adelaide, Australia
  • Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

  • Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

  • Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

  • Susanna Cooper, St. George’s University of London, UK
  • Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

  • Max Lennart Eckstein, University of Bayreuth, Germany
  • Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

  • Yuxue Cao, University of Queensland, Australia
  • Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced


In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

  • Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
  • Violeta Popovici, Ovidius University of Constanta, Romania
  • Yosra A. Helmy, University of Kentucky, USA

Cancers:

  • Antonio G. Solimando, Aldo Moro University of Bari, Italy
  • Linlin Guo, The Ohio State University Medical Center, USA
  • Ravindra Deshpande, Wake Forest School of Medicine, USA
  • Songli Zhu, Fred Hutchinson Cancer Research Center, USA
  • Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
  • Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA
  • Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
  • Rafał Watrowski, University of Freiburg, Germany
  • Ruben C. Petreaca, The Ohio State University, USA
  • Ruchi Roy, Rush University Medical Center, USA
  • Salvatore Cocuzza, University of Catania, Italy
  • Santosh Kumar Singh, Morehouse School of Medicine, USA
  • Sergei Boichuk, Kazan State Medical University, Russia
  • Simon John Christoph Soerensen, Stanford University, USA
  • Takuya Koie, Gifu University, Japan
  • Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
  • Teruki Nii, Kyushu University, Japan
  • Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

  • Kristen Haase, The University of British Columbia, Canada
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Makoto Endo, Kyushu University, Japan

Healthcare:

  • Tefera Tadesse, Addis Ababa University, Ethiopia
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

  • Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
  • José-María Sánchez-González, University of Seville, Spain
  • Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

  • Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
  • Rodolfo Reda, Sapienza University of Rome, Italy
  • Giulio Francesco Romiti, Sapienza University of Rome, Italy
  • Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
  • James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA

Medical Sciences:

  • Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

  • Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
  • Bhupendra Prajapati, Ganpat University, India
  • Van-An Duong, Gachon University, Republic of Korea
  • Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

  • Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

  • “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

  • “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

  • “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

  • “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

  • “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

  • “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

Dentistry Journal:

Healthcare:

JCM:

JPM:

Pharmaceutics:

Pharmacy:

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

7 August 2023
Tomography | Aims and Scope Update

We are pleased to announce that Tomography (ISSN: 2379-139X) held a successful meeting with the journal’s Editorial Board Members on 29 June 2023, chaired by Editor-in-Chief Prof. Dr. Emilio Quaia. With the Editorial Board Members’ suggestion and for the better development of Tomography in the future, we adjusted the aims and scope of Tomography, which are outlined below.

Aims and Scope

Mission statement: Tomography (ISSN: 2379-139X) publishes peer-reviewed original articles spanning all aspects of (bio)medical imaging in healthcare and life biological science including microscopy, ranging from basic research to clinical science, clinical applications, and innovations in imaging data science, as well as artificial intelligence.

Topics of interest: Topics of interest include the advancement of (bio)medical imaging technologies across multiple scales in space and time, including cross-sectional imaging modalities (for example: US, CT, MRI, and PET), as well as other imaging modalities (for example, bioluminescence, photoacoustic, optical and electronic microscopy, optical imaging, cryo-electron microscopy, fiber optic imaging, and optical computed tomography). Original articles on advances in biomedical imaging hardware and software, novel imaging contrast mechanisms and agents, imaging informatics, imaging analysis, and AI applications in biomedical imaging, as well as on chemical and molecular probe developments are welcome.

For more journal information, please check the following link: https://www.mdpi.com/journal/tomography/about.

27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

5 July 2023
Prof. Dr. Pascal N. Tyrrell Appointed Section Editor-in-Chief of Section “Artificial Intelligence in Medical Imaging” in Tomography

We are pleased to announce that Prof. Dr. Pascal N. Tyrrell has been appointed Section Editor-in-Chief of the “Artificial Intelligence in Medical Imaging” Section in Tomography (IF: 1.9, ISSN: 2379-139X).

Name: Prof. Dr. Pascal N. Tyrrell

Affiliation:
1. Department of Medical Imaging, University of Toronto, Toronto, ON M5T 1W7, Canada;
2. Department of Statistical Sciences, University of Toronto, Toronto, ON M5T 1W7, Canada;
3. Institute of Medical Science, University of Toronto, Toronto, ON M5T 1W7, Canada.

Interests: artificial Intelligence; biostatistics; machine learning; medical images

Website: https://medical-imaging.utoronto.ca/faculty/pascal-tyrrell


The following is a short Q&A with
Prof. Dr. Pascal N. Tyrrell, who shared his vision for the journal with us, as well as his views of the research area and open access publishing:

1. What appealed to you about Tomography that made you want to take the role as its Section Editor-in-Chief?
The aims and scope of our journal Tomography fit my area of research perfectly! I also enjoy the fact that the journal includes both imaging and optical modalities which provides ample opportunity for cross-pollination in this interesting area of science.

2. What is your vision for the Section?
I think artificial intelligence is an inevitable technological advance that will provide incredible progress in all areas of research and development it is applied to. As a journal, we should get out in front of these advances in order to contribute and be a part of the change that is happening in the field of tomography.

3. What does the future of this field of research look like?
The future of AI in tomography is bright. What an exciting time for scientists! Be prepared for a tsunami of impactful AI research applications.

4. What do you think of the development of open access in publishing?
Open access publishing’s main advantage is free access to scientific literature (especially for researchers in developing countries) resulting in a wider readership. The biggest challenge, of course, is quality control. If done right, open access publishing will contribute to the democratization of science in a sustainable way.

We look forward to Prof. Dr. Pascal N. Tyrrell’s contribution to the continued success of the journal.

4 July 2023
Welcoming New Editorial Board Members of Tomography

We are pleased to announce that four new scholars were appointed Editorial Board Members (EBMs) of Tomography (ISSN: 2379-139X) in May 2023. We wish our new members success in both their research and the development of the journal.

Name

Affiliation

Prof. Dr. Cristian T. Badea

Duke University Medical Center, USA

Prof. Dr. Eric Sigmund

NYU Langone Medical Center, USA

Prof. Dr. Michael T. McMahon

Kennedy Krieger Institute, USA
Johns Hopkins School of Medicine, USA

Dr. Sumit Isharwal

University of Virginia Health System, USA

Further details about the Editorial Board can be found at the following link: https://www.mdpi.com/journal/tomography/editors.

Tomography is recruiting prestigious scholars from around the world to join our Editorial Board. To apply for this position, recommend potential candidates, or request further information, please contact the Tomography Editorial Office (tomography@mdpi.com) with the following two files attached:

  • A full academic CV;
  • A short cover letter that details your interest in and enthusiasm for the position.

Tomography Editorial Office

Back to TopTop